Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy

  1. Sordo-Bahamonde, C.
  2. Lorenzo-Herrero, S.
  3. Granda-Díaz, R.
  4. Martínez-Pérez, A.
  5. Aguilar-García, C.
  6. Rodrigo, J.P.
  7. García-Pedrero, J.M.
  8. Gonzalez, S.
Revue:
Molecular Cancer

ISSN: 1476-4598

Année de publication: 2023

Volumen: 22

Número: 1

Type: Révision

DOI: 10.1186/S12943-023-01845-4 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus